National Cancer Institute: Investigating the Impact of CMG Technologies on Cancer Care Delivery (R01)

Opportunity ID: 42999

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-09-004
Funding Opportunity Title: Understanding the Effects of Emerging Cellular, Molecular, and Genomic Technologies on Cancer Health Care Delivery(R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.399 — Cancer Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Oct 06, 2008
Last Updated Date:
Original Closing Date for Applications: Jan 07, 2012
Current Closing Date for Applications: Jan 07, 2012
Archive Date: Feb 07, 2012
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
Special district governments
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Private institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
County governments
For profit organizations other than small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following:
Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Non-domestic (non-U.S.) Entities (Foreign Organizations); U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: -Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites grant applications for health services research that address the utilization of emerging cellular, molecular, and genetic or genomic (CMG) technologies in cancer care. The studies will assess CMG technologies in relation to: (a) quality of care; (b) organizational barriers and change factors in utilization; (c) cost and cost-effectiveness; (d) disparities in access and efficacy; (e) monitoring of cross-sectional patterns of care and time trends; (f) impact on existing standards of care; and (g) influence on cancer outcomes such as incidence, progression, mortality, survival, and quality of life. This FOA specifically encourages research on commercially available CMG clinical tools already in use, as well as experimental tools in the later stages of development and/or in the regulatory approval pipeline. The funding opportunity also encourages interdisciplinary collaborations between health services researchers and those in the clinical and/or translational sciences.
-Mechanism of Support. This FOA utilizes the NIH Research Project Grant (R01 mechanism and runs in parallel with an FOA of identical scientific scope, PA-09-005 which uses the exploratory/developmental (R21) grant mechanism.
-Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-09-004.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.399 ADOBE-FORMS-B Use for submissions intended for due dates of January 25, 2010 and beyond PKG00014821 Dec 21, 2009 Oct 14, 2010 View
93.399 ADOBE-FORMS-A Adobe-Forms-A PKG00009571 Jan 05, 2009 Feb 20, 2010 View
93.399 ADOBE-FORMS-B1 Supersedes ADOBE-FORMS-B PKG00021875 Oct 14, 2010 Jan 07, 2012 View

Package 1

Mandatory forms

42999 RR_SF424_1_2-1.2.pdf

42999 PerformanceSite_1_3-1.3.pdf

42999 RR_OtherProjectInfo_1_2-1.2.pdf

42999 RR_KeyPersonExpanded_1_2-1.2.pdf

42999 PHS398_CoverPageSupplement_1_4-1.4.pdf

42999 PHS398_ResearchPlan_1_3-1.3.pdf

42999 PHS398_Checklist_1_3-1.3.pdf

Optional forms

42999 PHS_CoverLetter_1_2-1.2.pdf

42999 PHS398_ModularBudget-1.1.pdf

42999 RR_Budget-1.1.pdf

42999 RR_SubawardBudget-1.2.pdf

Package 2

Mandatory forms

42999 RR_SF424-1.1.pdf

42999 RR_KeyPersonExpanded-1.1.pdf

42999 RR_OtherProjectInfo-1.1.pdf

42999 RR_PerformanceSite-1.1.pdf

42999 PHS398_CoverPageSupplement-1.1.pdf

42999 PHS398_ResearchPlan-1.1.pdf

42999 PHS398_Checklist-1.1.pdf

Optional forms

42999 PHS398_CoverLetter-1.1.pdf

42999 PHS398_ModularBudget-1.1.pdf

42999 RR_Budget-1.1.pdf

42999 RR_SubawardBudget-1.2.pdf

Package 3

Mandatory forms

42999 RR_SF424_1_2-1.2.pdf

42999 RR_OtherProjectInfo_1_3-1.3.pdf

42999 RR_KeyPersonExpanded_1_2-1.2.pdf

42999 PerformanceSite_1_4-1.4.pdf

42999 PHS398_ResearchPlan_1_3-1.3.pdf

42999 PHS398_CoverPageSupplement_1_4-1.4.pdf

42999 PHS398_Checklist_1_3-1.3.pdf

Optional forms

42999 RR_Budget-1.1.pdf

42999 RR_SubawardBudget-1.2.pdf

42999 PHS_CoverLetter_1_2-1.2.pdf

42999 PHS398_ModularBudget-1.1.pdf


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *